Funding
← Back to your selection

BlueYard Capital

blueyard.com ↗Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026

BlueYard Capital backs foundational technologies from pre-seed through Series A, with recorded activity in developer infrastructure, digital assets and biotechnology.

Foundational technology at an early stage

BlueYard operates from the United States and Europe and describes an investment focus spanning computation, engineering, biology and chemistry, and crypto infrastructure. Its stated initial investment range is $500,000 to $5 million, typically as lead or co-lead from pre-seed through Series A.

Activity recorded on RoundOS

Recorded RoundOS activity includes Boxd’s cloud development environments, Cryptio’s digital-asset accounting software and Transcripta Bio’s drug-discovery work. Sensible Biotechnologies adds an mRNA-platform example. This is the set represented in this database, with each event linked to its own article.

Sources
Rounds participated in
3
Confirmed lead rounds
1
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$71M
2 disclosed · full round size, not this investor’s share

By stage

Series A2
Pre-seed1

By primary sector

Biotech2
Developer tools1

By country

Netherlands1
United Kingdom1
United States1

Rounds

3 in this selection
Boxd

A cloud development environment that gives each developer, coding agent, branch or pull request a persistent virtual machine to build and run software.

€2MPre-Seed
Lead
Transcripta Bio

AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases

$24MSeries A
Role not disclosed